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Abstract
Objective—Insomnia is a prevalent disorder in the United States and elsewhere. It has been 
associated with a range of somatic and psychiatric conditions, and adversely affects quality of life, 
productivity at work, and school performance. The objective of this study was to examine the 
trend in self-reported insomnia and excessive daytime sleepiness among US adults.
Methods—We used data of participants aged ≥18 years from the National Health Interview 
Survey for the years 2002 (30,970 participants), 2007 (23,344 participants), and 2012 (34,509 
participants).
Results—The unadjusted prevalence of insomnia or trouble sleeping increased from 17.5% 
(representing 37.5 million adults) in 2002 to 19.2% (representing 46.2 million adults) in 2012 
(relative increase: +8.0%) (P trend <0.001). The age-adjusted prevalence increased from 17.4% to 
18.8%. Significant increases were present among participants aged 18–24, 25–34, 55–64, and 65–
74 years, men, women, whites, Hispanics, participants with diabetes, and participants with joint 
pain. Large relative increases occurred among participants aged 18–24 years (+30.9%) and 
participants with diabetes (+27.0%). The age-adjusted percentage of participants who reported 
regularly having excessive daytime sleepiness increased from 9.8% to 12.7% (P trend <0.001). 
Significant increases were present in most demographic groups. The largest relative increase was 
among participants aged 25–34 years (+49%). Increases were also found among participants with 
hypertension, chronic obstructive pulmonary disease, asthma, and joint pain.
Conclusions—Given the deleterious effects of insomnia on health and performance, the 
increasing prevalence of insomnia and excessive daytime sleepiness among US adults is a 
potentially troubling development.
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Inadequate sleep as a public health concern has awakened from a deep slumber in recent 
decades [1]. Sleep health is a multidimensional field of study, and insomnia constitutes a 
key component of sleep health. The 2006 Institute of Medicine (IOM) report defined 
insomnia as “having difficulty falling asleep, maintaining sleep, or by short sleep duration, 
despite adequate opportunity for a full night’s sleep” [1]. Although several approaches to the 
nosology of insomnia exist (International Classification of Diseases-10, Diagnostic and 
Statistical Manual for Mental Disorders and the International Classification of Sleep 
Disorders) [2–4], national estimates of the prevalence of insomnia emanate from surveys 
that employ simple questions. Insomnia in the United States is common with reported 
population-based estimates ranging from about 15% to 24% [5,6].
Insomnia affects cognitive functioning [7], leads to depression [8], and may be comorbid 
with several psychiatric and medical conditions [9]. Furthermore, insomnia has been 
associated with heart disease in prospective and retrospective epidemiologic studies [10–13], 
and insomnia or symptoms thereof have been associated with increased mortality in some 
prospective studies [13–15] but not in others [16–18]. Among those who report to be 
suffering from insomnia, those who sleep fewer than six hours have been reported to be at 
increased risk for adverse health events [14]. Furthermore, insomnia increases the risk for 
automobile accidents and results in worse quality of life, increased disability, increased 
work absenteeism [19], and increased use of the health care system. The economic costs of 
insomnia are poorly understood but are nevertheless thought to be substantial: the direct 
economic costs attributed to insomnia were estimated to have been $13.9 billion in 1995 
[20], and estimates of total costs have ranged from $30 billion to $107.5 billion [20,21].
Given the range of adverse impacts and the economic costs associated with this disorder, 
having current information about trends in the prevalence of insomnia is vital to describing 
the scope of the problem in part to provide guidance about allocation of resources for 
preventing and treating insomnia. Because little information about recent trends in insomnia 
is available, our objective was to examine the trend on self-reported insomnia and excessive 
daytime sleepiness among adults in the United States.
2. Methods
We used cross-sectional data about insomnia from the National Health Interview Survey, 
which was available for the years 2002, 2007, and 2012 [22]. Since 1957, the National 
Health Interview Survey, conducted by the National Center for Health Statistics, has 
selected a representative sample of the civilian noninstitutionalized population using a 
multistage area probability design. During the first stage, a sample was drawn from a 
universe of primary sampling units (single counties or groups of adjacent counties or 
equivalent jurisdictions and/or metropolitan areas) that were divided into self-representing 
and non-self-representing primary sampling units. During the second stage, substrata were 
created from Census blocks or combined blocks, and clusters of dwelling units were created 
within the substrata and were subsequently systematically sampled. From selected dwelling 
units, one adult was randomly sampled for the Sample Adult component. Interviewers 
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employed by the U.S. Census Bureau received annual training in the procedures of the 
surveys and conducted the interviews using computer assisted personal interviewing with 
selected participants in their homes. Black and Hispanic persons were oversampled in all 
three surveys and Asians were oversampled in 2007 and 2012. A revised survey sampling 
design was introduced in 2006. The overall household response rates for the three years 
were 89.6%, 87.1%, and 77.6%, respectively. Household response rates were calculated as: 
interviewed households /(interviewed households + Type A non-response households). 
Reasons for being classified as a Type A non-response households include language 
problems, no one was at home after repeated contact attempts, family temporarily absent, 
refusal, household records rejected for insufficient data, household records rejected for other 
CAPI related problems, or other reasons for no interview. The final response rates for the 
Sample Adult component (final family response rate * [interviewed sample adults / eligible 
sample adults from Interviewed families]) were 74.3%, 67.8%, and 61.2%, respectively. 
Sampling weights were constructed based on probabilities of selection with adjustments for 
nonresponse and post-stratification. Because this study used publically available data, it was 
exempt from human subjects review.
Participants who responded affirmatively to the question “During the past 12 months, have 
you regularly had insomnia or trouble sleeping?” were defined as having insomnia. 
Participants who responded affirmatively to the question “During the past 12 months, have 
you regularly had excessive sleepiness during the day?” were deemed to have experienced 
excessive daytime sleepiness. Covariates included age, gender, and race or ethnicity (non-
Hispanic White, non-Hispanic Black, Hispanic, other).
We also examined the trends in several factors that may be related to insomnia including 
heavy drinking, binge drinking, smoking status, obesity, and employment status. Heavy 
drinking was defined as men who had on average more than two alcoholic beverages per day 
and women who had on average more than one alcoholic beverage per day. Binge drinking 
was defined as adults who on at least one day during the past year had five or more drinks 
(In the past year, on how many days did you have five or more drinks of any alcoholic 
beverage?). Current smoking was defined as having smoked at least 100 cigarettes during 
one’s life and still smoking at the time of the interview. Obesity was defined as a body mass 
index ≥30 kg/m2 calculated from self-reported weight and height. Participants who were 
seeking work were identified from the question “Which of the following was person doing 
last week?”
We limited analyses to adults aged ≥18 years. Age-adjusted estimates were calculated using 
the direct method with the year 2000 projected US population as the standard. Analyses 
using sampling weights were performed in SAS and SUDAAN to account for the complex 
sampling design.
3. Results
The number of participants aged ≥18 years were 31,044 in 2002, 23,393 in 2007, and 34,525 
in 2012. After excluding participants with missing values for the questions about insomnia 
and excessive daytime sleepiness, the sample sizes for this study were reduced to 30,970 
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(99.8%), 23,344 (99.8%), 34,509 (99.9%), respectively. Mean age increased significantly 
from 45.2 years in 2002 to 46.6 years in 2012 (P trend <0.001). The percentage of men 
remained stable (P trend = 0.799), and the percentage of white participants decreased 
significantly from 73.1% in 2002 to 67.2% in 2012 (P < 0.001).
The unadjusted prevalence of insomnia increased from 17.5% (an estimated 37.5 million 
adults) in 2002 to 19.2% (an estimated 46.2 million adults) in 2012. The age-adjusted 
prevalence of insomnia or trouble sleeping increased from 17.4% to 18.8% (relative 
increase: +8.0%, P trend <0.001). Significant increases were observed among participants 
aged 18–24 years, 25–34 years, 55–64 years, and 65–74 years, men, women, whites and 
Hispanics (Table 1). Among the demographic groups, the largest relative increase occurred 
among participants aged 18–24 years (+30.9%). The prevalence of insomnia tended to 
increase with age although the prevalence peaked among participants aged 55–64 years in 
2002 and 2012. In all three years, the prevalence was higher in women than men and was 
highest among whites.
Among participants with a comorbid condition, the prevalence of insomnia increased only 
among participants with diabetes and among participants with joint pain (Table 1). The 
relative increase in the prevalence of insomnia was particularly large among participants 
with diabetes (+27.0%). In each year, people with a chronic condition had a significantly 
higher prevalence of insomnia than those without the condition.
The prevalence of insomnia increased significantly among adults who were current smokers 
and those who were not, among those who were heavy drinkers and those who were not, 
among those who reported binge drinking and those who did not, and among those with a 
body mass index <30 kg/m2(Table 1). Furthermore, participants who were smokers, heavy 
drinkers, binge drinkers (2012 only), and obese had a significantly higher prevalence of 
insomnia than their counterparts in each of the survey years.
We also examined trends in adults reporting excessive daytime sleepiness (Table 2). The 
age-adjusted percentage of participants who reported regularly having excessive daytime 
sleepiness increased from 9.8% in 2002 (21.0 million adults) to 12.7% (30.5 million adults) 
in 2012 (P trend <0.001). Significant increases were present in all demographic groups 
except among participants of described as being of another race or ethnicity not white, 
black, or Hispanic. The largest relative increase was among participants aged 25–34 years 
(+49%). Furthermore, significant increases were also found among participants with 
hypertension, chronic obstructive pulmonary disease, asthma, and joint pain. In each year, 
adults with a chronic condition had a significantly higher prevalence of excessive daytime 
sleepiness than those without a chronic condition.
Among persons reporting insomnia only about a third also reported excessive daytime 
sleepiness during each survey. Trends in combinations of insomnia and excessive daytime 
sleepiness are shown in Table 3.
Figure 1 shows the age-adjusted estimates for several lifestyle factors that could have 
influenced the trend in insomnia. Significant trends were noted for binge drinking, smoking 
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status, obesity, and employment status (all P trend <0.001) but not heavy drinking (P trend = 
0.747).
4. Discussion
As the importance of adequate sleep has become increasingly appreciated, surveillance of 
sleep health is vital in describing the magnitude of a public health problem. Insomnia 
represents an important aspect of sleep health. Our analyses of national samples of US adults 
show that the percentages of adults who report regularly having insomnia or trouble sleeping 
and/or daytime sleepiness increased from 2002 to 2012. Our unadjusted estimates of 
insomnia increased from 17.5% to 19.2%, of excessive daytime sleepiness from 9.8% to 
12.7%, and the combination of insomnia and excessive daytime sleepiness from 6.2% to 
7.0%. Because of the adverse health consequences that have been attributed to insomnia, the 
increasing trend is an unwelcome development.
A prevalence of insomnia of about 10% among US adults is a commonly cited figure, but 
some estimates are much higher [1,23]. In an analysis of data from the 1979 National Survey 
of Psychotherapeutic Drug Use, the prevalence of insomnia among noninstitutionalized US 
adults aged 18–79 years was 35% [24]. Different approaches to defining insomnia are quite 
likely to produce varying prevalence estimates.
Previously, little was known about trends in the prevalence of insomnia in the United States, 
and, therefore, the information contained in this report helps to fill a gap in the knowledge 
base concerning sleep health. The increasing trend in the prevalence of insomnia and 
excessive daytime sleepiness in US adults that we demonstrated appears to parallel trends in 
several countries. In Finland, the prevalence of occasional insomnia in working age adults 
increased from the 1970s to the early 2000s [25]. In England, insomnia symptoms, insomnia 
of at least moderate severity, insomnia and fatigue, and insomnia diagnosis among survey 
participants aged 16– 64 years increased by 6%, 5%, 4%, and 3%, respectively, from 1993 
to 2007 [26]. In Taiwan, the prevalence of insomnia defined on the basis of International 
Classification of Diseases, Ninth Revision, Clinical Modification codes among National 
Health Insurance enrollees increased significantly from 2.5% in 2002 to 4.2% during 2009 
[27]. In Norway, the prevalence of insomnia increased significantly from 13.1% during 
1999–2000 to 15.2% during 2009–2010 [28].
The reasons why people experience insomnia are numerous and include behavioral, health-
related, psychological, and societal reasons [9]. Thus, population-level changes in any of 
these domains may have influenced the numbers of adults who experienced insomnia. The 
following explanations for increases in the prevalence of insomnia in other countries have 
been postulated: increases in health problems, increases in body mass index, changes in 
occupational factors such as stress and shiftwork, sleep habits, and the increasingly 
ubiquitous availability of electronic devices [25,28]. The jump in the prevalence of diabetes 
in the United States in recent decades is one example of how health problems have 
increased. Interestingly, the increase in reported insomnia by participants with diabetes was 
especially noteworthy. We noted significantly increasing trends in the prevalence of 
consumption of ≥5 drinks in a single day at least once during the past year and in obesity. 
Ford et al. Page 5













Furthermore, the percentage of adults seeking work was substantially higher in 2012 than 
earlier years. The trends of these factors could possibly have influenced the trend in the 
prevalence of insomnia [29–31]. However, the declining prevalence of smoking could have 
counterbalanced some of these other influences [32]. An alternative explanation for the 
findings is that the trends possibly reflect a type of awareness bias.
Young adulthood is a critical period during the life course when behaviors may start to settle 
in, and the foundations for chronic conditions that emerge later in life take hold. Thus, the 
large relative increase in the prevalence of insomnia that occurred among participants aged 
18–24 years is a cause for concern. This may reflect lifestyles including access to 
technologies and beverage choices that inhibit sleep. A personal history of insomnia has 
been shown to be a risk factor for subsequent insomnia [33], and consequently the onset of 
insomnia during early adulthood may portend a steeper burden of lifetime insomnia. 
Furthermore, insomnia has been linked to conditions such as obesity, diabetes, and 
cardiovascular disease, and if insomnia indeed plays a role in the etiology of these 
conditions, an early manifestation of insomnia could speed the onset of these conditions. 
Insomnia has also been linked to depression in prospective studies in young adults [34]. 
Unfortunately, information was not obtained about depression from respondents. 
Nevertheless, our findings should stimulate investigations into the reasons underlying the 
trend in young adulthood and of the potential ramifications thereof. From 1978 to 1988, the 
percentage of college students who reported being dissatisfied with their sleep increased 
from 24.4% to 53.4% [35].
Several limitations bear mention. First, the validity and reliability of the NHIS questions 
used to define insomnia and excessive daytime sleepiness are unproven. No uniformly 
accepted approach to defining insomnia in epidemiological studies and national surveillance 
systems currently exists although a number of insomnia questionnaires have been 
developed. Epidemiological definitions of insomnia differ from clinical definitions of 
insomnia that employ more stringent criteria [6,36]. Hence, we cannot say unambiguously 
that the trends we described for our epidemiological definition of insomnia might have been 
mimicked by a clinical definition of insomnia. The consistent wording of the questions 
across time increases confidence in the trends that we reported. Second, we were unable to 
distinguish primary from secondary insomnia. Third, all data of the NHIS were self-reported 
and subject to a variety of biases.
In conclusion, the prevalence of insomnia as reported by US adults rose steadily from 2002 
to 2012. If our results are confirmed by other data sources, more research on the reasons 
underlying any increase is warranted to develop evidence-based approaches in alleviating an 
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Age-adjusted percentages (95% confidence interval) of selected factors among US adults 
aged ≥18 years, National Health Interview Survey. Sample sizes ranged from 29,971 to 
31,044 in 2002, 22,331 to 23,393 in 2007, and 33,635 to 34,525 in 2012.
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